Technical Analysis for PTN - Palatin Technologies, Inc.

Grade Last Price % Change Price Change
grade B 1.32 -1.49% -0.02
PTN closed down 1.49 percent on Thursday, April 19, 2018, on 2.12 times normal volume.
13 Watchers
Intraday Alerts Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical PTN trend table...

Date Alert Name Type % Chg
Apr 19 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Apr 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Apr 19 Wide Bands Range Expansion 0.00%
Apr 19 Down 3 Days in a Row Weakness 0.00%
Apr 18 1,2,3 Pullback Bullish Bullish Swing Setup -1.49%
Apr 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.49%
Apr 18 Wide Bands Range Expansion -1.49%
Apr 17 1,2,3 Pullback Bullish Bullish Swing Setup -7.04%
Apr 17 Boomer Buy Setup Bullish Swing Setup -7.04%
Apr 17 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -7.04%

Older signals for PTN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:
Profile
Palatin Technologies, Inc., a biopharmaceutical company, engages in the development of peptide therapeutics for the treatment of diseases. Its drug development programs include Bremelanotide, a peptide melanocortin receptor agonist that is in Phase IIb clinical trials for the treatment of female sexual dysfunction; and PL-3994, a peptide mimetic natriuretic peptide receptor A agonist, which is in Phase I clinical trials for the treatment of cardiovascular and pulmonary indications, as well as melanocortin receptor-based compounds for treatment of obesity. The company was founded in 1986 and is based in Cranbury, New Jersey.
Is PTN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Apr 19 Why Poltronic SA. (WSE:PTN) Delivered An Inferior ROE Compared To The Industry
Apr 19 Premarket Losers as of 9:05 am (04/19/2018)
Apr 10 Premarket Gainers as of 9:05 am (04/10/2018)
Apr 6 HC Wainwright: Why The Upside Potential For Palatin Technologies Is Nearly Fivefold
Apr 6 Benzinga Pro's 5 Stocks To Watch Today
Apr 6 Benzinga's Top Upgrades, Downgrades For April 6, 2018
Apr 3 Palatin Technologies Presents Preclinical Oral Formulation Data on PL-8177, An Investigational Melanocortin Receptor 1 Agonist for Inflammatory Bowel Diseases
Mar 29 Does Poltronic SA.’s (WSE:PTN) PE Ratio Warrant A Buy?
Mar 29 With An ROE Of 242.93%, Has Palatin Technologies Inc’s (NYSEMKT:PTN) Management Done Well?
Mar 26 AMAG Pharma files U.S. marketing application for HSDD med bremelanotide
See more PTN news...
Indicators
Indicator Value
52 Week High 1.59
52 Week Low 0.34
Average Volume 2,026,750
200-Day Moving Average 0.7923
50-Day Moving Average 1.0768
20-Day Moving Average 1.258
10-Day Moving Average 1.385
Average True Range 0.0953
ADX 44.15
+DI 27.41
-DI 17.04
Chandelier Exit (Long, 3 ATRs ) 1.3041
Chandelier Exit (Short, 3 ATRs ) 1.2709
Upper Bollinger Band 1.536
Lower Bollinger Band 0.98
Percent B (%b) 0.61
BandWidth 44.197138
MACD Line 0.0988
MACD Signal Line 0.0986
MACD Histogram 0.0002
Fundamentals Value
Market Cap 236.33 Million
Num Shares 179 Million
EPS -0.08
Price-to-Earnings (P/E) Ratio -16.50
Price-to-Sales 3.03
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.55
Resistance 3 (R3) 1.54 1.45 1.51
Resistance 2 (R2) 1.45 1.40 1.46 1.49
Resistance 1 (R1) 1.39 1.36 1.42 1.40 1.48
Pivot Point 1.30 1.30 1.32 1.31 1.30
Support 1 (S1) 1.24 1.25 1.27 1.25 1.16
Support 2 (S2) 1.15 1.21 1.16 1.15
Support 3 (S3) 1.09 1.15 1.13
Support 4 (S4) 1.10